| MeSH term | MeSH ID | Detail |
|---|---|---|
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Anemia, Iron-Deficiency | D018798 | 6 associated lipids |
| Thrombophlebitis | D013924 | 6 associated lipids |
| Jaundice, Neonatal | D007567 | 7 associated lipids |
| Mycobacterium Infections | D009164 | 7 associated lipids |
| Postoperative Hemorrhage | D019106 | 7 associated lipids |
| Leprosy | D007918 | 8 associated lipids |
| Renal Insufficiency, Chronic | D051436 | 9 associated lipids |
| Ascorbic Acid Deficiency | D001206 | 9 associated lipids |
| Hearing Disorders | D006311 | 10 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Liu Y et al. | New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. | 2004 | J. Am. Chem. Soc. | pmid:15198572 |
| Zager RA et al. | Parenteral iron nephrotoxicity: potential mechanisms and consequences. | 2004 | Kidney Int. | pmid:15200421 |
| Sengoelge G et al. | Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. | 2004 | Kidney Int. | pmid:15200437 |
| Lakatos A et al. | AlIII ion complexes of saccharic acid and mucic acid: a solution and solid-state study. | 2004 | Chemistry | pmid:15007818 |
| Folkert VW | Safety of high doses of non-dextran irons. | 2003 May-Jun | Semin Dial | pmid:12753696 |
| Okada DR et al. | Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. | 2003 Mar-Apr | J Nucl Cardiol | pmid:12673182 |
| Mukhin IV and Nikolenko VIu | [Experimental systemic enzyme therapy of gouty and primary glomerulonephritis]. | 2003 Jul-Aug | Eksp Klin Farmakol | pmid:14558349 |
| Souqiyyeh MZ and Shaheen FA | Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209438 |
| Zolezzi M | Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. | 2003 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18209437 |
| Flotats A and Carrió I | Non-invasive in vivo imaging of myocardial apoptosis and necrosis. | 2003 | Eur. J. Nucl. Med. Mol. Imaging | pmid:12638039 |
| Silverberg DS et al. | Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. | 2003 | Isr. Med. Assoc. J. | pmid:12811950 |
| Singh J and Gupta KP | Calcium glucarate prevents tumor formation in mouse skin. | 2003 | Biomed. Environ. Sci. | pmid:12747003 |
| Yang W et al. | The first fluorescent sensor for D-glucarate based on the cooperative action of boronic acid and guanidinium groups. | 2003 | Chem. Commun. (Camb.) | pmid:12703826 |
| Edwards JH | Clinical review of the newer intravenous iron therapy options. | 2003 | Nephrol Nurs J | pmid:12674953 |
| Ballinger JR et al. | Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. | 2003 | Nucl Med Commun | pmid:12717079 |
| Chuang CL et al. | Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. | 2003 | Nephrol. Dial. Transplant. | pmid:12543894 |
| Folkert VW et al. | Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. | 2003 | Am. J. Kidney Dis. | pmid:12612989 |
| Beshara S et al. | Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. | 2003 | Br. J. Haematol. | pmid:12614222 |
| Apostoli P et al. | Relationship between PCBs in blood and D-glucaric acid in urine. | 2003 | Toxicol. Lett. | pmid:12919720 |
| Deicher R et al. | High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. | 2003 | Kidney Int. | pmid:12846772 |
| Fishbane S | Safety issues with iron sucrose. | 2003 | Am. J. Kidney Dis. | pmid:12666081 |
| Séronie-Vivien S et al. | Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report. | 2003 | Med. Oncol. | pmid:14514981 |
| Folkert VW | Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. | 2003 | Nephrol Nurs J | pmid:14621635 |
| Breborowicz M et al. | Effect of iron sucrose on human peritoneal mesothelial cells. | 2003 | Eur. J. Clin. Invest. | pmid:14636286 |
| Tutor-Crespo MJ et al. | Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin. | 2003 | Epilepsy Res. | pmid:14642999 |
| Blaustein DA et al. | The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. | 2003 | Kidney Int. Suppl. | pmid:14531777 |
| Colfer M | Achieving optimal patient outcomes with intravenous iron. | 2003 | Nephrol Nurs J | pmid:14533524 |
| Geisser P | Reactivity of iron compounds. | 2003 | Am. J. Kidney Dis. | pmid:14582056 |
| Danielson BG and Beshara S | Pharmacokinetics and utilization of iron sucrose. | 2003 | Am. J. Kidney Dis. | pmid:14582057 |
| Schröder CH | The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. | 2003 | Pediatr. Nephrol. | pmid:12750985 |
| Hanausek M et al. | Detoxifying cancer causing agents to prevent cancer. | 2003 | Integr Cancer Ther | pmid:15035900 |
| Tutor-Crespo MJ et al. | [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. | 2002 Oct 16-31 | Rev Neurol | pmid:12402220 |
| Breymann C | Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. | 2002 Nov-Dec | Blood Cells Mol. Dis. | pmid:12547241 |
| Dittrich E et al. | Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. | 2002 Jan-Feb | Perit Dial Int | pmid:11929146 |
| Shaheen FA et al. | Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. | 2002 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:17660651 |
| Bayoumeu F et al. | [Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation]. | 2002 | Ann Fr Anesth Reanim | pmid:11878118 |
| Arteaga de Murphy C et al. | 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. | 2002 | Int J Pharm | pmid:11897407 |
| Calcium-D-glucarate. | 2002 | Altern Med Rev | pmid:12197785 | |
| Hermida J et al. | Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. | 2002 | Clin. Lab. | pmid:12146576 |
| Perewusnyk G et al. | Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. | 2002 | Br. J. Nutr. | pmid:12117422 |
| Sandstad O et al. | D-glucaric acid in common duct bile and relation to choledocholithiasis. | 2002 | Scand. J. Gastroenterol. | pmid:11989842 |
| Ibert M et al. | Determination of the side-products formed during the nitroxide-mediated bleach oxidation of glucose to glucaric acid. | 2002 | Carbohydr. Res. | pmid:12039549 |
| Harmankaya O and Eran A | Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. | 2002 | Ren Fail | pmid:12071600 |
| Zager RA et al. | Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. | 2002 | Am. J. Kidney Dis. | pmid:12087566 |
| Michaud L et al. | Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. | 2002 | Clin Nutr | pmid:12381338 |
| Oldham FB | Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? | 2002 | Am. J. Kidney Dis. | pmid:12407662 |
| Silverberg DS et al. | The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. | 2002 | Clin. Nephrol. | pmid:12227725 |
| Wali A et al. | Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. | 2002 | J Pak Med Assoc | pmid:12532571 |
| Yee J and Besarab A | Iron sucrose: the oldest iron therapy becomes new. | 2002 | Am. J. Kidney Dis. | pmid:12460028 |
| Bauer S et al. | Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers. | 2002 | Eur. J. Clin. Pharmacol. | pmid:12483450 |
| Hosoya S et al. | Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. | 2002 | FEMS Microbiol. Lett. | pmid:12044674 |
| Boase S and Miners JO | In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. | 2002 | Br J Clin Pharmacol | pmid:12445028 |
| Rooyakkers TM et al. | Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. | 2002 | Eur. J. Clin. Invest. | pmid:11886426 |
| Kooistra MP et al. | Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. | 2002 | Eur. J. Clin. Invest. | pmid:11886430 |
| Bayoumeu F et al. | Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. | 2002 | Am. J. Obstet. Gynecol. | pmid:11904617 |
| Hörl WH | Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. | 2001 Sep-Oct | Perit Dial Int | pmid:11757843 |
| Prakash S et al. | Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. | 2001 May-Jun | Perit Dial Int | pmid:11475345 |
| Chandler G et al. | Intravenous iron sucrose: establishing a safe dose. | 2001 | Am. J. Kidney Dis. | pmid:11684551 |
| Stoves J et al. | A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. | 2001 | Nephrol. Dial. Transplant. | pmid:11328902 |
| Pach J et al. | New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. | 2001 | Prz. Lek. | pmid:11450331 |
| Breymann C et al. | Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. | 2001 | Am. J. Obstet. Gynecol. | pmid:11262469 |
| Pollak A et al. | Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. | 2001 | Pediatrics | pmid:11134438 |
| Charytan C et al. | Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. | 2001 | Am. J. Kidney Dis. | pmid:11157370 |
| Kosch M and Schaefer RM | [Iron deficiency. When parenteral substitution?]. | 2001 | MMW Fortschr Med | pmid:11247361 |
| Merbouh N et al. | Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. | 2001 | Carbohydr. Res. | pmid:11675028 |
| Kaltwasser JP et al. | Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. | 2001 | J. Rheumatol. | pmid:11708414 |
| Duffy CI | Iron sucrose or ferric gluconate? | 2001 | Am. J. Kidney Dis. | pmid:11728988 |
| Gasche C et al. | Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. | 2001 | Am. J. Gastroenterol. | pmid:11513178 |
| Fishbane S and Kowalski EA | The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. | 2000 Nov-Dec | Semin Dial | pmid:11130261 |
| Johnson LL et al. | Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. | 2000 Nov-Dec | J Nucl Cardiol | pmid:11144474 |
| Yoshimi N et al. | Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. | 2000 | Int. J. Oncol. | pmid:10601547 |
| Bailie GR et al. | Parenteral iron use in the management of anemia in end-stage renal disease patients. | 2000 | Am. J. Kidney Dis. | pmid:10620537 |
| Descombes E and Fellay G | Improved response to erythropoietin therapy with long-term continuous iron supplementation. | 2000 | Nephron | pmid:10657727 |
| Fujita K et al. | Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). | 2000 | Life Sci. | pmid:10821120 |
| Wiersema AM et al. | Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. | 2000 | Cardiovasc Surg | pmid:10799826 |
| Fujii Y et al. | Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). | 2000 | Biomed. Pharmacother. | pmid:10759292 |
| Gulick AM et al. | Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. | 2000 | Biochemistry | pmid:10769114 |
| Wargovich MJ et al. | Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. | 2000 | Carcinogenesis | pmid:10837003 |
| Parkkinen J et al. | Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. | 2000 | Nephrol. Dial. Transplant. | pmid:11071973 |
| Kao HH et al. | Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy. | 2000 | Chang Gung Med J | pmid:11126152 |
| van Iperen CE et al. | Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. | 2000 | Crit. Care Med. | pmid:10966249 |
| Krafft A et al. | Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. | 2000 | Acta Obstet Gynecol Scand | pmid:10949245 |
| Gombotz H et al. | Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. | 2000 | Acta Anaesthesiol Scand | pmid:10903019 |
| Van Wyck DB et al. | Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. | 2000 | Am. J. Kidney Dis. | pmid:10873877 |
| Monterrubio R et al. | A common regulator for the operons encoding the enzymes involved in D-galactarate, D-glucarate, and D-glycerate utilization in Escherichia coli. | 2000 | J. Bacteriol. | pmid:10762278 |
| Lubberink M et al. | Quantification aspects of patient studies with 52Fe in positron emission tomography. | 1999 | Appl Radiat Isot | pmid:10581681 |
| Braun L et al. | Different induction of gulonolactone oxidase in aromatic hydrocarbon-responsive or -unresponsive mouse strains. | 1999 | FEBS Lett. | pmid:10606751 |
| Mariani G et al. | Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. | 1999 | J. Nucl. Med. | pmid:10565778 |
| Jahn M et al. | The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. | 1999 | Carbohydr. Res. | pmid:10614067 |
| Weisbach V et al. | Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. | 1999 | Transfusion | pmid:10335995 |
| Nakatsugawa S et al. | Inhibitory effect of ND2001 on spontaneous multiple metastasis of NC 65 tumors derived from human renal cancer cells intradermally transplanted into nude mice. | 1999 | Anticancer Drugs | pmid:10211554 |
| Picaud JC et al. | [Iron supplementation in preterm infants treated with erythropoietin]. | 1999 | Arch Pediatr | pmid:10394459 |
| Krafft A et al. | Erythropoietic quality of maternal milk. | 1999 | Lancet | pmid:10475225 |
| Lim PS et al. | Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. | 1999 | Nephrol. Dial. Transplant. | pmid:10534512 |
| Gasche C et al. | Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. | 1999 | Digestion | pmid:10343140 |
| Edelson SB and Cantor DS | Autism: xenobiotic influences. | 1998 Nov-Dec | Toxicol Ind Health | pmid:9891912 |
| Kuramitsu Y et al. | A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin. | 1998 | Anticancer Drugs | pmid:9491797 |
| Nonaka D et al. | Gelatinous bone marrow transformation complicated by self-induced malnutrition. | 1998 | Acta Haematol. | pmid:9792939 |
| Sato K and Shiraki M | Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy. | 1998 | Endocr. J. | pmid:9881891 |
| Kuramitsu Y et al. | ND-2001 suppresses lung metastasis of human renal cancer cells in athymic mice. | 1998 | Anticancer Drugs | pmid:9823433 |